Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
9/25/2023
AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space
9/24/2023
PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
9/24/2023
Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
9/21/2023
Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...
9/20/2023
A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
9/20/2023
Everest Medicines Enters into Collaboration and License Agreement with...
9/19/2023
Novartis, BeiGene Agree to Terminate Deal for Cancer Drug Candidate
9/18/2023
GenScript Expands Range of Reagent Services, Adding Circular RNA and L...
9/15/2023
JW Therapeutics and 2Seventy Bio Announce Strategic Partnership to Acc...
9/15/2023
Cure Genetics, Frametact to Develop Brain Disease Gene Therapies in $6...
9/13/2023
LIB Thera and Hasten Biopharma Announce $325M Strategic Collaboration ...
9/13/2023
Clover Biopharma Launches Quadrivalent Influenza Vaccine in Mainland C...
9/13/2023
AriBio, Shanghai Pharma to Commercialize Oral Alzheimer's Drug AR1001
9/13/2023
Exelixis and Insilico Enter Global Licensing Pact for Anticancer Candi...
9/12/2023
Chinese Pharma Companies Expand Foothold in Africa
9/7/2023
MSD Plans to Boost New Product Launch and Pharma R&D in China
8/31/2023
Financial-related Company News Digest (August 2023)
8/31/2023
MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
8/30/2023
Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
8/29/2023
CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution
8/28/2023
Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...
8/28/2023
Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
8/25/2023
State Council Adopts New Action Plan for High-quality Development of P...
8/25/2023
Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
8/24/2023
CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
8/24/2023
Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
8/24/2023
Review of China Performance of Leading MNCs in China H1/2023 (Updated)
8/23/2023
Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
8/22/2023
Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
8/22/2023
CSPC, Insilico and XtalPi Sign Strategic Collaboration on AI Innovativ...
Page:
11
/
13
Total number of articles:
365
:
[First]
[<<]
[9]
[10]
[11]
[12]
[13]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit